These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 5346073)

  • 1. Enhancement of percutaneous absorption by the use of volatile: nonvolatile systems as vehicles.
    Coldman MF; Poulsen BJ; Higuchi T
    J Pharm Sci; 1969 Sep; 58(9):1098-102. PubMed ID: 5346073
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of particle size and vehicle on the percutaneous absorption of fluocinolone acetonide.
    Barrett CW; Hadgraft JW; Caron GA; Sarkany I
    Br J Dermatol; 1965 Nov; 77(11):576-8. PubMed ID: 5853251
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance of vehicle composition. I. Relationship between topical vehicle composition, skin penetrability, and clinical efficacy.
    Ostrenga J; Steinmetz C; Poulsen B
    J Pharm Sci; 1971 Aug; 60(8):1175-9. PubMed ID: 5127090
    [No Abstract]   [Full Text] [Related]  

  • 4. Penetration kinetics of four drugs in the human skin. Influences of various pharmaceutical vehicles on penetration in vitro.
    Zesch A; Schaefer H
    Acta Derm Venereol; 1974; 54(2):91-7. PubMed ID: 4133027
    [No Abstract]   [Full Text] [Related]  

  • 5. Percutaneous penetration of steroids in man.
    Feldmann RJ; Maibach HI
    J Invest Dermatol; 1969 Jan; 52(1):89-94. PubMed ID: 5761932
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of plasma cortisol in patients treated with fluocinonide cream with either open or occlusive application.
    Pozzo G; Prandini BD
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):40-2. PubMed ID: 5291632
    [No Abstract]   [Full Text] [Related]  

  • 7. Percutaneous absorption. Influence of temperature and hydration.
    Stoughton RB
    Arch Environ Health; 1965 Oct; 11(4):551-4. PubMed ID: 5837406
    [No Abstract]   [Full Text] [Related]  

  • 8. The in vitro penetration of fluocinonide through human skin from different volumes of DMSO.
    Coldman MF; Kalinovsky T; Poulsen BJ
    Br J Dermatol; 1971 Nov; 85(5):457-61. PubMed ID: 5132160
    [No Abstract]   [Full Text] [Related]  

  • 9. Significance of vehicle composition. II. Prediction of optimal vehicle composition.
    Ostrenga J; Steinmetz C; Poulsen B; Yett S
    J Pharm Sci; 1971 Aug; 60(8):1180-3. PubMed ID: 5127091
    [No Abstract]   [Full Text] [Related]  

  • 10. SCALP DERMATOSES. TREATMENT WITH FLUOCINOLONE ACETONIDE IN PROPYLENE GLYCOL.
    LUBOWE II
    Skin (Los Angeles); 1964 Sep; 3():267-9. PubMed ID: 14202034
    [No Abstract]   [Full Text] [Related]  

  • 11. [Percutaneous resorption of corticosteroids. II. Resorption of flucocinolone acetonide through normal rat skin and its influence].
    Brode E
    Arzneimittelforschung; 1968 May; 18(5):580-5. PubMed ID: 4303730
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of formulation on the clinical response to topical fluocinolone acetonide.
    Portnoy B
    Br J Dermatol; 1965 Nov; 77(11):579-81. PubMed ID: 5853252
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of vehicles in the percutaneous absorption of corticosteroids. An experimental and clinical study.
    Sarkany I; Hadgraft JW; Caron GA; Barrett CW
    Br J Dermatol; 1965 Nov; 77(11):569-75. PubMed ID: 5322445
    [No Abstract]   [Full Text] [Related]  

  • 14. [Letter: Percutaneous absorption of steroids].
    Stüttgen G
    Dtsch Med Wochenschr; 1974 Sep; 99(39):1944. PubMed ID: 4424534
    [No Abstract]   [Full Text] [Related]  

  • 15. Vehicle effects on in vitro percutaneous absorption through rat and human skin.
    Hilton J; Woollen BH; Scott RC; Auton TR; Trebilcock KL; Wilks MF
    Pharm Res; 1994 Oct; 11(10):1396-400. PubMed ID: 7855041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of ointment and cream vehicles for a new topical steroid, fluclorolone acetonide.
    Malone T; Haleblian JK; Poulsen BJ; Burdick KH
    Br J Dermatol; 1974 Feb; 90(2):187-95. PubMed ID: 4819137
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimicrobial properties of a propylene glycol based topical therapeutic agent.
    Olitzky I
    J Pharm Sci; 1965 May; 54(5):787-8. PubMed ID: 5845896
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of polyoxypropylene 15 stearyl ether and propylene glycol on percutaneous penetration rate of diflorasone diacetate.
    Turi JS; Danielson D; Woltersom JW
    J Pharm Sci; 1979 Mar; 68(3):275-80. PubMed ID: 423113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of mixtures of topical corticosteroids as a mechanism for improving total drug bioavailability: a preliminary report.
    Poulsen BJ; Chowhan ZT; Pritchard R; Katz M
    Curr Probl Dermatol; 1978; 7():107-20. PubMed ID: 752447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INFLUENCE OF DIMETHYLSULFOXIDE (DMSO) ON HUMAN PERCUTANEOUS ABSORPTION.
    STOUGHTON RB; FRITSCH W
    Arch Dermatol; 1964 Nov; 90():512-7. PubMed ID: 14200645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.